BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir

  • Wen Fang Tang
  • , Yu Hsiu Chang
  • , Cheng Chin Lin
  • , Jia Rong Jheng
  • , Chung Fan Hsieh
  • , Yuan Fan Chin
  • , Tein Yao Chang
  • , Jin Ching Lee
  • , Po Huang Liang
  • , Chia Yi Lin
  • , Guan Hua Lin
  • , Jie Yun Cai
  • , Yu Li Chen
  • , Yuan Siao Chen
  • , Shan Ko Tsai
  • , Ping Cheng Liu
  • , Chuen Mi Yang
  • , Tolou Shadbahr
  • , Jing Tang
  • , Yu Lin Hsu
    • Chih Heng Huang, Ling Yu Wang, Cheng Cheung Chen, Jyh Hwa Kau, Yi Jen Hung, Hsin Yi Lee, Wen Chieh Wang, Hui Ping Tsai*, Jim Tong Horng*
*Corresponding author for this work

Research output: Contribution to journal › Journal Article › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science